GSK submits US regulatory application for single-dose Tafenoquine for Plasmodium vivax malaria Ruby Khatun Khatun1 Dec 2017 4:32 AM GMTLondon, UK, Geneva, Switzerland: GSK and Medicines for Malaria Venture (MMV) announced the submission of a new drug application (NDA) by GSK to the...